Professional Documents
Culture Documents
Abstract
Background: Previous studies have shown that the carpal tunnel syndrome seems to occur more frequently in
patients with diabetes mellitus and might be associated with the duration of diabetes mellitus, microvascular
complications and degree of glycaemic control. Primary aim was to determine if type 2 diabetes can be identified
as a risk factor for carpal tunnel syndrome after adjusting for possible confounders. Furthermore, the influence of
duration of diabetes mellitus, microvascular complications and glycaemic control on the development of carpal
tunnel syndrome was investigated.
Methods: Retrospective, case–control study using data from electronic patient charts from the Isala (Zwolle, the
Netherlands). All patients diagnosed with carpal tunnel syndrome in the period from January 2011 to July 2012
were included and compared with a control group of herniated nucleus pulposus patients.
Results: A total of 997 patients with carpal tunnel syndrome and 594 controls were included. Prevalence of
type 2 diabetes was 11.5% in the carpal tunnel syndrome group versus 7.2% in the control group (Odds
Ratio 1.67 (95% confidence interval 1.16-2.41)). In multivariate analyses adjusting for gender, age and body
mass index, type 2 diabetes was not associated with carpal tunnel syndrome (OR 0.99 (95% CI 0.66-1.47)).
No differences in duration of diabetes mellitus, microvascular complications or glycaemic control between
groups were detected.
Conclusion: Although type 2 diabetes was more frequently diagnosed among patients with carpal tunnel
syndrome, it could not be identified as an independent risk factor.
Keywords: Carpal tunnel syndrome, Type 2 diabetes mellitus, Risk factor
Background are identified as the main risk factors for CTS [1]. In
Carpal tunnel syndrome (CTS) is one of the most fre- addition, diabetes mellitus (DM) is also considered as a
quent compression neuropathies of the upper limb [1]. risk factor [3-7]. Furthermore some researchers found a
Due to entrapment of the median nerve between the higher incidence of CTS in patients with pre-diabetes [8],
flexor tendons of the hand in the carpal tunnel symp- nevertheless screening for DM in patients with CTS is not
toms, like tingling and noctural burning pain, occur [1]. recommended [9]. Literature suggests also a relationship
The combination of these clinical symptoms together between HbA1c, duration of DM, microvascular compli-
with positive signs by physical examination and nerve cations and CTS [10-12]. However, many studies investi-
conduction studies (NCS) is the most valid way of diag- gated DM as a risk factor for musculoskeletal disorders of
nosing CTS [1]. the hand and shoulder in general and not for CTS in par-
The prevalence of CTS in the general population is ticular [11,13].
approximately 2.1% for men and 3.0% for women [2]. Aim of the present study was to determine if type 2
Obesity, hypothyroidism, pregnancy, rheumatoid arthritis, diabetes mellitus (T2DM) can be identified as a risk
osteoarthritis and occupational factors like repetitive work factor for CTS. Furthermore, we investigated the influence
of diabetes duration, glycaemic control and presence of
microvascular complications on the development of CTS.
* Correspondence: s.hendriks@isala.nl
1
Diabetes Centre, Isala, Zwolle, the Netherlands
Full list of author information is available at the end of the article
© 2014 Hendriks et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Hendriks et al. BMC Musculoskeletal Disorders 2014, 15:346 Page 2 of 5
http://www.biomedcentral.com/1471-2474/15/346
Table 1 Results of univariate analyses between the CTS group and the control group
Variables CTS group Control group p-value OR (95% CI)
(n =997) (n =594)
T2DM 115 (11.5) 43 (7.2) 0.006 1.67 (1.16-2.41)
Gender (female) 710 (71.2) 293 (49.3) <0.001 2.54 (2.06-3.14)
Age (years) 55.7 ± 15.2 49.3 ± 13.0 <0.001 1.03 (1.02-1.04)
BMI (kg/m2)a 28.3 ± 5.4 26.7 ± 4.6 <0.001 1.06 (1.04-1.09)
Systolic RR (mmHg) 138.8 ± 21.4 138.6 ± 20.6 0.870 1.00 (0.99-1.01)
Age DM patients (years) 65.6 ± 12.7 60.1 ± 13.7 0.021 1.03 (1.01-1.06)
Gender DM patients (female) 74 (64.3%) 21 (48.8%) 0.078 1.89 (0.93-3.84)
BMI DM patients (kg/m2) 31.2 ± 5.7 29.1 ± 5.1 <0.001 1.07 (1.04-1.10)
Median diabetes duration (months)b 103 (55–172) 80 (47–166) 0.389 1.00 (1.00-1.01)
c
HbA1c (% (mmol/mol)) 7.1 ± 3.2 (54 ± 11) 7.3 ± 3.2 (56 ± 12) 0.567 0.99 (0.95-1.03)
Microvascular complicationsd 46 (40.0%) 13 (30.2%) 0.402 0.68 (0.28-1.67)
Metformin 69 (60.0%) 26 (60.5%) 0.582 1.15 (0.70-1.89)
SU-derivate 34 (29.6%) 7 (16.3%) 0.09 2.19 (0.89-5.40)
Insulin 52 (45.2%) 18 (41.9%) 0.673 1.17 (0.57-2.37)
Values are depicted as number (%), mean ± SD or median with 25th and 75th percentile.
a
Imputation was used for 229 patients with a missing value for BMI in the CTS group and for 12 controls.
b
2 missing values in the CTS group and 16 in the control group.
c
6 missing values in the CTS group and 20 in the control group.
d
12 missing values in the CTS group and 19 the control group.
patients in our region. Moreover, although both the op- consultation. The choice to use surgery-treated HNP pa-
erated CTS and HNP patients had the same kind of pre- tients as a control population is also a topic for debate.
operative screening in which the presence of DM was Smaller studies have described a relationship between
assessed, we cannot exclude the possibility of more in- DM and HNP, so although inconclusive, the prevalence
tensive screening in one of the two groups which may of T2DM could be higher among these persons than in
have resulted in a different DM prevalence within and the general population [14]. Additionally, as overweight
between the two groups. Furthermore, differential mis- is identified as a risk factor for the occurrence of lumbar
classification bias could have occurred because conser- disc herniation, and overweight is also is a major risk
vatively treated CTS patient have had no preoperatively factor for T2DM, this could have resulted in a higher
prevalence of DM in the HNP population compared
Table 2 Multivariate analysis of T2DM as an risk factor with the general population [15,16]. Therefore, shared
for CTS adjusting for gender, age and BMI risk factors, such as BMI, should be taken into account
model (n =1591) B p-value OR (95% CI) when interpreting the results of our study. At last, it
Model 1 should be noticed that, due to the amount of missing
T2DM 0.571 0.003 1.77 (1.22-2.58) data any relevant relationships cannot be excluded based
Gender a
0.945 <0.001 2.57 (2.08-3.18) on the present study.
Similar to our results, a study among 156 CTS patients
Model 2
and 473 age and sex matched controls derived from a
T2DM 0.389 0.048 1.48 (1.00-2.17)
Dutch population register could not find a relation be-
Gendera 0.953 <0.001 2.59 (2.09-3.22) tween DM and CTS [17]. Furthermore, a study from
b
BMI 0.060 <0.001 1.06 (1.04-1.09) Greece found an identical prevalence of DM in a CTS
Model 3 population as compared to control subjects from the gen-
T2DM −0.014 0.946 0.99 (0.66-1.47) eral population [18]. On the other hand a significant rela-
tion was found in a larger cohort of 3391 CTS patients
Gendera 0.976 <0.001 2.65 (2.13-3.31)
and 13.564 matched controls (OR 1.51 (95% BI 1.24-1.84))
Age 0.034 <0.001 1.03 (1.03-1.04)
[4]. A systematic review indicated DM as a risk factor for
BMIb 0.064 <0.001 1.07 (1.04-1.09) CTS (OR 2.2 (95% BI 1.5-3.1)) [3]. However, not all stud-
B = coefficient of logistic regression.
a
ies included in this review controlled for age differences in
Male gender is reference category.
b
Imputation was used for 229 patients with a missing value for BMI in the CTS
multivariate models, which was found to be an important
group and for 12 controls. confounding variable in the present study.
Hendriks et al. BMC Musculoskeletal Disorders 2014, 15:346 Page 5 of 5
http://www.biomedcentral.com/1471-2474/15/346
Taken together, it could be hypothesized that BMI and 6. Karpitskaya Y, Novak CB, Mackinnon SE: Prevalence of smoking, obesity,
age, both well known risk factors for T2DM, are import- diabetes mellitus and thyroid disease in patients with carpal tunnel
syndrome. Ann Plas Surg 2002, 48:269–273.
ant risk factors for CTS as well, and may explain the rela- 7. Tseng CH, Liao CC, Kuo CM, Sung FC, Hsieh DPH, Tsai CH: Medical and
tionship found between T2DM and CTS in other studies. non-medical correlates of carpal tunnel syndrome in a Taiwan cohort of
Despite the limitations of the present study, i.e. choice of one million. Eur J Neurol 2012, 19:91–97.
8. Gulliford MC, Latinovic R, Charlton J, Hughes RAC: Increased incidence of
control group, limited generalizability due to the second- carpal tunnel syndrome up to 10 years before diagnosis of diabetes.
ary setting, magnitude of missing data and small sample Diabetes Care 2006, 29:1929–1930.
size, this is a hypothesis worth further testing. 9. De Rijk MC, Vermeij FH, Suntjens M, Van Doorn PA: Does a carpal tunnel
syndrome predict an underlying disease? J Neurol Neurosurg Psychiatry
2007, 78:635–637.
Conclusion 10. Singh R, Gamble G, Cundy T: Lifetime risk of symptomatic carpal tunnel
syndrome in Type 1 diabetes. Diabet Med 2005, 22:625–630.
Although type 2 diabetes was more frequently diagnosed 11. Ramchurn N, Mashamba C, Leitch E, Arutchelvam V, Narayanan K, Weaver J,
among patients with carpal tunnel syndrome, it could not Hamilton J, Heycock C, Saravanan V, Kelly C: Upper limb musculoskeletal
be identified as an independent risk factor. BMI and age, abnormalities and poor metabolic control in diabetes. Eur J Intern Med
2009, 20:718–721.
which are well known risk factors for T2DM, are import- 12. Perkins BA, Olaleye D, Bril V: Carpal tunnel syndrome in patients with
ant risk factors for CTS as well and may confound the diabetic polyneuropathy. Diabetes Care 2002, 25:565–569.
previously found relationship between type 2 diabetes and 13. Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allieu Y: Dupuytren’s
disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus.
CTS. J Hand Surg Am 1995, 20:109–114.
14. Sakellaridis N: The influence of diabetes mellitus on lumbar intervertebral
Abbreviations disk herniation. Surg Neurol 2006, 66:152–154.
CTS: Carpal tunnel syndrome; DM: Diabetes mellitus; T2DM: Type 2 diabetes 15. Saftic R, Grgic M, Ebling B: Case–control study of risk factors for lumbar
mellitus; NCS: Nerve conduction studies; HNP: Herniated nucleus pulposus; intervertebral disc herniation in Croatian island populations. Croat Med J
DTC: Diagnosis-treatment-combination; BMI: Body mass index; OR: Odds ratio; 2006, 47:593–600.
CI: Confidence interval. 16. Shiri R, Lallukka T, Karppinen J, Viikari-Juntura E: Obesity as a risk factor for
sciatica: a meta-analysis. Am J Epidemiol 2014, 179:929–937.
17. De Krom MC, Kester AD, Knipschild PG, Spaans F: Risk factors for carpal
Competing interests
tunnel syndrome. Am J Epidemiol 1990, 132:1102–1110.
All authors declare that they have no competing interests.
18. Stamboulis E, Vassilopoulos D, Kalfakis N: Symptomatic focal
mononeuropathies in diabetic patients: increased or not? J Neurol 2005,
Authors’ contributions 252:448–452.
SHH (guarantor), PRD, KHG, PH, HJGB and NK designed the study; SHH and
PRD acquired the data used in this study; SHH, PRD and NK analysed the doi:10.1186/1471-2474-15-346
data; SHH and KHG performed the statistical analyses; SHH and PRD drafted Cite this article as: Hendriks et al.: Type 2 diabetes seems not to be a
the manuscript. SHH, PRD, KHG, PH, HJGB and NK participated in risk factor for the carpal tunnel syndrome: a case control study. BMC
interpretation of the data and in revision of the manuscript. All authors read Musculoskeletal Disorders 2014 15:346.
and approved the final manuscript. PRD, NK and HJGB supervised the study.
Acknowledgements
Steven H. Hendriks is the guarantor of this work and, as such, had full access
to all the data in the study and takes responsibility for the integrity of the
data and the accuracy of the data analysis.
Author details
1
Diabetes Centre, Isala, Zwolle, the Netherlands. 2Department of General
Practice, University of Groningen, Groningen, the Netherlands. 3Department
of Plastic Surgery, Isala, Zwolle, the Netherlands. 4Department of Internal
Medicine, University of Groningen, Groningen, the Netherlands. 5Langerhans,
Medical Research Group, Zwolle, the Netherlands.